UniCredit's Mustier to Step Down as CEO Over Strategy Rift

Jean Pierre Mustier said it had become clear in recent months that the core pillars of his strategy for the Italian bank "no longer correspond to the board's current thinking."

 
Amazon Makes Mac Commitment, Opening Door to Apple Developers

Tech giants Amazon and Apple are joining forces to support the growing number of companies developing apps and other software for Apple devices.

 
Exxon Slashes Spending, Writes Down Assets

The struggling Texas oil giant is retreating from a plan to increase spending to boost its oil and gas production by 2025 and preparing to slash the book value of its assets by up to $20 billion.

 
Tesla to Enter S&P 500 at Full Weight in December

The electric-vehicle maker will be added to the broad stock-market gauge before the start of trading Dec. 21, meaning most index-tracking funds that follow the S&P 500 will engage in a flurry of trading the Friday before.

 
Bankruptcy Judge Denies Lenders' Request to Block Sale of New York Sports Clubs Owner

Town Sports, operator of the New York Sports Clubs and Lucille Roberts gym chains, got a green light to move forward with a plan to wrap up a sale of its assets to its lenders and an entity managed by investment banking firm Lepercq de Neuflize & Co.

 
Credit Suisse Proposes Lloyds CEO as Chairman

Credit Suisse has proposed that Antonio Horta-Osorio, the outgoing CEO of Lloyds Banking Group, becomes the Swiss bank's next chairman.

 
SBM Offshore Faces Swiss Probe Over Legacy Bribery Allegations

Oil-services firm SBM Offshore is facing an investigation by the Swiss government into bribery allegations that the company said it has already paid hundreds of millions of dollars to resolve in three other countries.

 
Zoom's Pandemic-Fueled Boom Continues

The videoconferencing company posted another quarter of record sales and again lifted its outlook as remote working and distance schooling drags on during the pandemic.

 
Novavax Delays Covid-19 Vaccine Study Over Manufacturing Issues

Novavax has delayed starting a large, decisive clinical trial of its Covid-19 vaccine in the U.S. and Mexico to sometime in the coming weeks due to manufacturing issues, versus an earlier plan to start by the end of November.

 
Moderna Asks FDA to Authorize Vaccine

The drugmaker is seeking approval for its Covid-19 vaccine after it was shown to be 94.1% effective, keeping the shot on track for use in the U.S. by year's end, alongside Pfizer and BioNTech.

(END) Dow Jones Newswires

December 01, 2020 05:15 ET (10:15 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.